Clinical Trial Update: Effects of LP28 on Immunity Enhancement in the Elderly [NA]

View source ↗

Summary

This clinical trial update indicates that Synbio Tech Inc. is recruiting for a study of the LP28 probiotic to enhance immunity in elderly individuals, with atte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Cold

Drugs mentioned

• LP28 (Lactobacillus paracasei LP28)

Snippet

Sponsor: Synbio Tech Inc. | Conditions: Common Cold, Immunity | NA | Status: RECRUITING